Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update

Reshma Rani; Vinit Kumar; Flavio Rizzolio

doi:10.1021/acsmedchemlett.7b00523

Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update

ACS Med Chem Lett. 2017 Dec 28;9(1):4-5. doi: 10.1021/acsmedchemlett.7b00523. eCollection 2018 Jan 11.

Authors

Reshma Rani¹, Vinit Kumar², Flavio Rizzolio^{3

4}

Affiliations

¹ Amity Institute of Biotechnology, Amity University, Noida 201313, India.
² Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida 201313, India.
³ Department of Molecular Sciences and Nanosystems, Ca' Foscari University, Venezia 30123, Italy.
⁴ Pathology Unit, Department of Translational Research, National Cancer Institute and Center for Molecular Biomedicine-CRO, Aviano 33081, Italy.

Abstract

In the past few years since our viewpoint on carbon nanoparticles was first published in 2013 (Kumar, V.; Toffoli, G.; Rizzolio, F. ACS Med. Chem. Lett.2013, 4 (11), 1012-1013), a considerable progress has been made in the area of synthesis, functionalization, and applications of fluorescent carbon nanoparticles (CNPs). This update aims to highlight some key points achieved in the last 4 years in the development of CNPs with a particular emphasis on the approaches to ameliorate clinical applications of CNPs as therapeutics, diagnostics, and theranostics agents.

Publication types

Editorial